WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015118549) ENCAPSULATED BIOLOGICALLY ACTIVE AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/118549    International Application No.:    PCT/IL2015/050149
Publication Date: 13.08.2015 International Filing Date: 10.02.2015
IPC:
A61K 9/51 (2006.01), A61K 31/7048 (2006.01), A61P 35/00 (2006.01), A61P 31/00 (2006.01), A61K 36/9066 (2006.01), A61K 9/22 (2006.01)
Applicants: F&C LICORICE LTD. [IL/IL]; Deshanim Industrial Park 8 Deshanim Road 28226 Kiriat Ata (IL)
Inventors: KODER, Saul; (IL)
Agent: LOTAN, Mirit; Reinhold Cohn and Partners P.O.B. 13239 61131 Tel-Aviv (IL)
Priority Data:
61/938,047 10.02.2014 US
Title (EN) ENCAPSULATED BIOLOGICALLY ACTIVE AGENTS
(FR) AGENTS BIOLOGIQUEMENT ACTIFS ENCAPSULÉS
Abstract: front page image
(EN)The present invention relates to a platform for enhanced bioavailability and delivery of biologically active compounds. Specifically, the invention provides an orally administrable composition comprising an encapsulated biologically active agent and encapsulated inhibitors of gut enzymatic and/or transport activity. The invention further relates to pharmaceutical and nutraceutical compositions, as well as to consumable products comprising the orally administrable composition.
(FR)La présente invention concerne une plateforme pour améliorer la biodisponibilité et l'administration de composés biologiquement actifs. L'invention concerne en particulier une composition pouvant être administrée par voie orale comprenant un agent biologiquement actif encapsulé et des inhibiteurs encapsulés de l'activité de transport et/ou enzymatique de l'intestin. L'invention concerne en outre des compositions pharmaceutiques et nutraceutiques, ainsi que des produits consommables comprenant la composition pouvant être administrée par voie orale.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)